Three new publications using AimPlex flow-based multiplex immunoassays! see more at: https://lnkd.in/gQ5EAxyJ
关于我们
AimPlex Biosciences, Inc. leverages years of assay development expertise to offer comprehensive solutions in biomedical testing. Founded in August 2011, the company is committed to developing and providing high-quality, cost-effective immunoassay reagents for flow cytometry analyses. Our immunoassay products employ existing flow cytometry analytical platforms for sensitive detection. AimPlex Bio offers a rapidly-evolving, customizable test menu, as well as custom immunoassay services to develop new multiplex assay panels to improve customer assay performance and efficiency. Currently, we offer over 400 non-Luminex* bead-based immunoassays for conventional flow cytometers such as the Accuri C6*, FACSCalibur*, FACSCanto*, LSRII*, CyAn*, EC800* and FC500*. *Trademarks?are the property of?their respective owners.
- 网站
-
https://www.aimplexbio.com
AimPlex Biosciences, Inc.的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Pomono,California
- 类型
- 私人持股
- 创立
- 2011
- 领域
- Immunoassays、Flow Cytometry、Bead-based multiplex assays、Assay development、International distribution、Assay reagents、Assay design和Custom multiplexed immunoassays
地点
-
主要
1802 N. Orange Grove Avenue
US,California,Pomono,91767
AimPlex Biosciences, Inc.员工
动态
-
Happy New Year 2025! AimPlex Bio has released new assays: Human MMP-10 (Total), Mouse IL-18, and Non-Human Primate BDNF. Learn more at: https://lnkd.in/gHztPKkD.
-
-
View the AimPlex Publication List at: https://lnkd.in/gziH_6kE
-
-
Three new publications using AimPlex Flow-Based Multiplex Immunoassays! https://lnkd.in/gyHvWdkR
-
-
New Canine assays: ANGPT-1/Angiopoietin-1, https://lnkd.in/gEwMfzBk, BDNF, https://lnkd.in/gbGcH4XQ
-
-
Two new publications citing AimPlex flow-based multiplex immunoassays: https://lnkd.in/gzXumxxp
-
-
AimPlex Bio has released new assays: Human CD23/Fcε RII/sCD23 (https://lnkd.in/gDrnUMf2), and Human YKL40/CHI3L1/Chitinase 3-like 1 (https://lnkd.in/gbhFKGQc).
-
-
Three more new publications using AimPlex Flow-based multiplex immunoassay technologies. Learn more https://lnkd.in/gXVaPB-n
-